Denison Mines stock dips as Phoenix uranium build budget rises to C$600 million

Denison Mines stock dips as Phoenix uranium build budget rises to C$600 million

New York, January 7, 2026, 09:46 (EST) — Regular session

  • Denison Mines shares fell about 0.8% in early trade.
  • Focus is on final Canadian approvals for the Phoenix uranium project and a higher capital cost estimate.
  • Uranium prices have held near $82/lb, while sector trading was mixed.

Denison Mines Corp shares slipped 0.8% to $3.26 in early New York trading on Wednesday. The uranium developer has traded in a tight range since the open.

Investors are circling the company’s Phoenix project in northern Saskatchewan, where Denison says it is ready to take a final investment decision — a formal go-ahead to build — once federal approvals land. Denison put post-decision initial capital costs at C$600 million and said the estimate assumes a final investment decision at the end of February; CEO David Cates said the company “stands ready” to move into construction. PR Newswire

The broader tape has not been much help. Uranium was last quoted around $82 a pound on Tuesday and Trading Economics’ model points to about $82.85 by the end of the quarter, while the Global X Uranium ETF and heavyweight miner Cameco were both slightly lower in early trade. Trading Economics

Phoenix is designed as an in-situ recovery, or ISR, operation — dissolving uranium underground and pumping the solution to surface instead of digging an open pit or underground mine. Trade coverage this week has framed Phoenix as a potential first for that method in the Athabasca Basin, with Denison targeting first production in mid-2028 if approvals arrive this quarter. Investing News Network (INN)

Denison is one of the more closely watched uranium names because its Wheeler River project sits in a top-tier mining district and it also has interests in other Saskatchewan assets, including the McClean Lake joint venture. The company’s shares trade in the U.S. under the symbol DNN. Reuters

On the charts, the stock is hovering near the top end of its 52-week range, after printing an intraday low around $3.22 on Wednesday. The 52-week range is $1.08 to $3.42, data on Investing.com showed. Investing

The next scheduled catalyst on many traders’ calendars is Denison’s next results update, but the company has not yet listed a Q4 reporting date on its investor calendar, which currently runs through the November 6 release for Q3 2025. Denison Mines Corp.

There are obvious ways this can go sideways. A slower regulatory timeline would push out the start of construction, and the higher capital estimate puts more weight on cost control as contracting ramps up. Uranium prices can move fast in either direction, and that volatility tends to wash straight through to the equities.

Stock Market Today

  • REGN crosses above average 12-month target; shares trade at $820
    January 8, 2026, 7:11 AM EST. Regeneron Pharmaceuticals (REGN) shares rose to $820.00, topping the consensus 12-month target of $816.30 set by analysts. When a target is reached, analysts typically reassess: downgrade on valuation or lift targets on improving fundamentals. The Zacks coverage universe spans 20 targets; the average hides a wide range, from a low $605.00 to a high $970.00, with a standard deviation of $87.334. The move highlights the wisdom of crowds in pricing, inviting investors to judge whether $816.30 represents ongoing upside or a stretched level. Ratings show Strong Buy or Buy signals outweighing Hold and Sell signals, with an average rating of 1.68 on a 1 (Strong Buy) to 5 (Strong Sell) scale. Source: Zacks via Quandl.
Broadcom stock today: AVGO in focus after bond pricing details land and Wi‑Fi 8 chips debut
Previous Story

Broadcom stock today: AVGO in focus after bond pricing details land and Wi‑Fi 8 chips debut

NIO stock ticks up as CATL battery-swap pact, millionth-vehicle milestone hit tape
Next Story

NIO stock ticks up as CATL battery-swap pact, millionth-vehicle milestone hit tape

Go toTop